ABCL (AbCellera Biologics Inc. Common Shares) Stock Analysis - Hedge Fund Holdings

AbCellera Biologics Inc. Common Shares (ABCL) is a publicly traded Healthcare sector company. As of May 21, 2026, ABCL trades at $4.54 with a market cap of $1.27B and a P/E ratio of -9.37. ABCL moved +12.72% today. Year to date, ABCL is +33.24%; over the trailing twelve months it is +118.66%. Its 52-week range spans $1.89 to $6.52. Analyst consensus is strong buy with an average price target of $8.75. Rallies surfaces ABCL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ABCL stock?

Hedge funds tracked by Rallies that own ABCL include Orbimed Advisors, Duquesne Family, and Polen Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AbCellera Biologics Inc. Common Shares.

ABCL Key Metrics

Key financial metrics for ABCL
MetricValue
Price$4.54
Market Cap$1.27B
P/E Ratio-9.37
EPS$-0.48
Dividend Yield0.00%
52-Week High$6.52
52-Week Low$1.89
Volume115.64K
Avg Volume0
Revenue (TTM)$79.21M
Net Income$-143.96M
Gross Margin0.00%

Top Hedge Funds Holding ABCL

  • Orbimed Advisors holds 3.34M shares of ABCL, changed -20.00% as of Jun 30, 2025.
  • Duquesne Family holds 659.75K shares of ABCL, changed +0.00% as of Dec 31, 2023.
  • Polen Capital holds 102.51K shares of ABCL, changed -61.93% as of Dec 31, 2025.

Latest ABCL News

Recent ABCL Insider Trades

  • Montalbano John S. bought 20.00K (~$95.40K) on May 14, 2026.
  • Thermopylae Holdings Ltd. bought 38.00K (~$130.72K) on Feb 27, 2026.
  • Booth Andrew bought 42.60K (~$145.69K) on Feb 27, 2026.

ABCL Analyst Consensus

6 analysts cover ABCL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.75.

Common questions about ABCL

Who owns ABCL stock?
Hedge funds tracked by Rallies that own ABCL include Orbimed Advisors, Duquesne Family, and Polen Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AbCellera Biologics Inc. Common Shares.
Does Rallies show 13F holders for ABCL?
Yes. Rallies tracks hedge fund and 13F ownership data for ABCL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ABCL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ABCL. It does not provide personalized investment advice.
ABCL

ABCL